ALFA Filings
Every announcement, straight from the exchange
Every Brooks Laboratories other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements with these filters
Brooks Laboratories Ltd has submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory requirements.
Brooks Laboratories is informing shareholders about the availability of the Annual Report for FY 2025-26 and requesting KYC updates in compliance with regulatory requirements.
Brooks Laboratories Limited filed its shareholding pattern as per Regulation 31(1)(b). The filing details holdings across promoters, institutions, and public shareholders.
Brooks Laboratories filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with no new material deviations.
Atul Ranchal, promoter of Brooks Laboratories Ltd, submitted a declaration under SEBI Takeover Regulations for FY 2025-26. The filing confirms that the promoter and promoter group made no new share encumbrances during the year, other than those already disclosed. This is a routine annual regulatory compliance disclosure.